Showing results (161-170 of 203) with videos related to
Sort By:
Pageof 21
Annals of Hematology|March 24, 2017
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemiaAnna Both, Jürgen Krauter, Frederik Damm, et al.Blood|June 10, 2010
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 studyWolfgang A Bethge, Thoralf Lange, Christoph Meisner, et al.Annals of the New York Academy of Sciences|June 12, 2003
Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemiaTim H Brummendorf, Inci Ersoz, Ulrike Hartmann, et al.Annals of Neurology|February 9, 2002
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphomaUlrich Herrlinger, Martin Schabet, Wolfram Brugger, et al.Cancer Research|May 24, 2018
Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell TransformationMarkus W Löffler, Daniel J Kowalewski, Linus Backert, et al.BMC Medical Genetics|August 17, 2018
First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implicationsMarkus W Löffler, Julia Steinhilber, Franz J Hilke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemiaFrederik Damm, Michael Heuser, Michael Morgan, et al.Oncotarget|February 5, 2017
A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and "pan-leukemia" antigensLinus Backert, Daniel Johannes Kowalewski, Simon Walz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemiaFrederik Damm, Tina Oberacker, Felicitas Thol, et al.Blood|March 5, 2011
Integrative prognostic risk score in acute myeloid leukemia with normal karyotypeFrederik Damm, Michael Heuser, Michael Morgan, et al.Pageof 21